Recent News

• 04.17.2025 - OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025
• 04.17.2025 - OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025
• 04.04.2025 - OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program
• 04.04.2025 - OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program
• 03.17.2025 - OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders
• 03.17.2025 - OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders

Recent Filings

• 04.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.08.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.03.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 04.03.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 04.02.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 04.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.01.2025 - 8-K Current report
• 03.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.28.2025 - 8-K Current report
• 03.21.2025 - 10-K/A Annual report [Section 13 and 15(d), not S-K Item 405]